Ardsley Advisory Partners’s Allergan plc AGN Stock Holding History

Ardsley Advisory Partners’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-2,000	Closed	-$486K	–	175
2017 Q2	$486K	Buy	+2,000	New	+$470K	0.08%	95
2016 Q4	–	Sell	-2,500	Closed	-$576K	–	187
2016 Q3	$576K	Sell	2,500 -1,500	-38%	-$367K	0.09%	87
2016 Q2	$924K	Buy	4,000 +2,000	+100%	+$461K	0.16%	67
2016 Q1	$536K	Hold	2,000	–	–	0.08%	75
2015 Q4	$625K	Sell	2,000 -1,000	-33%	-$298K	0.08%	69
2015 Q3	$815K	Sell	3,000 -1,000	-25%	-$307K	0.2%	68
2015 Q2	$1.21M	Hold	4,000	–	–	0.15%	73
2015 Q1	$1.19M	Hold	4,000	–	–	0.17%	74
2014 Q4	$1.03M	Hold	4,000	–	–	0.16%	72
2014 Q3	$965K	Buy	4,000 +1,000	+33%	+$224K	0.13%	74
2014 Q2	$669K	Hold	3,000	–	–	0.09%	121
2014 Q1	$618K	Buy	3,000 +1,000	+50%	+$198K	0.09%	121
2013 Q4	$336K	Buy	+2,000	New	+$313K	0.04%	114
2013 Q3	–	Sell	-3,000	Closed	-$379K	–	184
2013 Q2	$379K	Buy	+3,000	New	+$340K	0.08%	91

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Ardsley Advisory Partners's AGN Position: Q3 2017 in Review

Ardsley Advisory Partners sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 2,000 shares — an estimated $486K sold.

Ardsley Advisory Partners first reported a position in AGN in Q2 2013 and held it in 14 quarters. The position peaked at $1.21M in Q2 2015. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

Ardsley Advisory Partners reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
Ardsley Advisory Partners sold 2,000 Allergan plc shares in Q3 2017, an estimated $486K.
Ardsley Advisory Partners first reported a position in Allergan plc in Q2 2013 and held it in 14 quarters.
Ardsley Advisory Partners's Allergan plc position peaked at $1.21M in Q2 2015.
1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Ardsley Advisory Partners's 13F filing for Q3 2017, filed 14 Nov 2017.